hce_cmu
111年
英文
第 38 題
📖 題組：
＿36＿ his diagnosis, Mike’s wife Veronica had made a full-time job of seeking treatment options for her husband. And as of last summer, when Mike’s doctors said they had nothing else to offer him, Veronica knew they’d have to widen their search. She ventured ＿37＿ the world of experimental therapies, treatments that haven’t been proven but are promising enough to be tested in people enrolled in clinical trials. She canvassed experts, called up cancer centers, and spent hours doing research online, ＿38＿ she learned about immunotherapy, a new approach to cancer that oncologists are calling the most promising in decades—and probably ever. Veronica read of an ongoing Duke University trial of a drug called pembrolizumab that is approved and used to treat melanoma and was showing early promise against cancers in other parts of the body too. It’s the same drug that just a few months later would send former President Jimmy Carter’s melanoma, which had spread to his brain, into remission seemingly overnight. In August 2015, Mike learned he’d been accepted into a trial for that same drug. In principle, immunotherapy is simple. It’s a way to trigger the immune system’s ability to seek out and destroy invaders. That’s how the body fights off bacteria and viruses. But it doesn’t do that with cancer, which occurs when healthy cells ＿39＿ to outsmart those built-in defenses. That’s where immunotherapy comes in. “Instead of using ＿40＿ forces, like a scalpel or radiation beams, it takes advantage of the body’s own natural immune reaction against cancer,” says Dr. Steven Rosenberg, an immunotherapy pioneer and chief of surgery and head of tumor immunology at the National Cancer Institute (NCI). These strategies don’t target cancer itself but work on the body’s ability to fight it. These therapies, administered in pill or IV form, trigger the immune system to fight cancer cells while keeping healthy cells intact. For someone as frail as Mike, that was an especially appealing prospect.
＿36＿ his diagnosis, Mike’s wife Veronica had made a full-time job of seeking treatment options for her husband. And as of last summer, when Mike’s doctors said they had nothing else to offer him, Veronica knew they’d have to widen their search. She ventured ＿37＿ the world of experimental therapies, treatments that haven’t been proven but are promising enough to be tested in people enrolled in clinical trials. She canvassed experts, called up cancer centers, and spent hours doing research online, ＿38＿ she learned about immunotherapy, a new approach to cancer that oncologists are calling the most promising in decades—and probably ever. Veronica read of an ongoing Duke University trial of a drug called pembrolizumab that is approved and used to treat melanoma and was showing early promise against cancers in other parts of the body too. It’s the same drug that just a few months later would send former President Jimmy Carter’s melanoma, which had spread to his brain, into remission seemingly overnight. In August 2015, Mike learned he’d been accepted into a trial for that same drug. In principle, immunotherapy is simple. It’s a way to trigger the immune system’s ability to seek out and destroy invaders. That’s how the body fights off bacteria and viruses. But it doesn’t do that with cancer, which occurs when healthy cells ＿39＿ to outsmart those built-in defenses. That’s where immunotherapy comes in. “Instead of using ＿40＿ forces, like a scalpel or radiation beams, it takes advantage of the body’s own natural immune reaction against cancer,” says Dr. Steven Rosenberg, an immunotherapy pioneer and chief of surgery and head of tumor immunology at the National Cancer Institute (NCI). These strategies don’t target cancer itself but work on the body’s ability to fight it. These therapies, administered in pill or IV form, trigger the immune system to fight cancer cells while keeping healthy cells intact. For someone as frail as Mike, that was an especially appealing prospect.
- A how
- B why
- C whose
- D where
思路引導 VIP
請觀察空格前的動作「doing research online」與空格後的事件「she learned about immunotherapy」。如果我們把「網路研究」想像成一個獲取資訊的「範疇」或「平台」，後面的學習行為與這個平台之間存在著什麼樣的情境關聯？你會用哪種邏輯（例如：時間、原因、或所在場合）來連結這兩個部分呢？
🤖
AI 詳解
AI 專屬家教
恭喜你準確掌握了這個文法細節！這題的關鍵在於理解先行詞與後續子句的邏輯關係。在句子中，主角在網路（online）進行研究，而「學習到免疫療法」這件事，正是在這個虛擬的數位空間或情境中發生的，因此選擇連結空間概念的詞彙非常精準。
關係副詞的抽象空間概念
這裡的 where 擔任關係副詞，用來引導一個補充說明的子句。雖然 online 在詞性上常作為副詞，但在這裡它與前面的 research 共同構建了一個「資訊發生的場合」。在英文語法中，當我們要把某個情境、媒介（如網路、書籍）或活動視為一個抽象的「地點」時，使用 where 是非常道地且專業的表達方式，這能讓語句在銜接上顯得流暢而不生硬。
▼ 還有更多解析內容